chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore arm; mildly sick for 2 days; Initial information regarding an unsolicited valid non-serious case received from a consumer via social media on 17-Oct-2020.  This case is linked to case 2020SA296404 (Cluster).  This case involves a patient of unknown demographics who was mildly sick for 2 days (illness) and sore arm (pain in extremity), while the patient received vaccine Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, unspecified time after receiving the vaccine, the patient was mildly sick for 2 days (illness) afterwards along with a sore arm (pain in extremity).  It was not reported if the patient received a corrective treatment.  Outcome of both the events were unknown, at the time of reporting.  There will be no information available on the batch number for this case.      The reporter assessed the causal relationship with suspect vaccine as related.
Subsequent to receiving an unspecified dose of Engerix B the pt experienced transient elevated liver function tests.  The most recent information received reports the condition of the pt is unknown.
Pregnant (due 11/4/2021) no symptoms prior to vaccination, first dose of covid Pfizer vaccine 8/13/2021 shot in left arm. Skin rash/sores begin 8/15/2021 under arms, under breasts, upper thighs/groin, spreading to neck.  Reported to community physicians 8/18/21,  Obgyn on 8/19/2021. Asked about rash being vaccine side effect. They were both unsure of what is causing. Told to take OTC Benadryl and to contact primary care physician should rash spread. By the time of 2nd dose of Pfizer vaccine, some rash sores beginning to clear up. After 2nd dose was received as shot in left arm on 9/3/2021, rash became worse in groin, causing pain and also became worse under arms and across stomach and neck. New sore beginning on left eyelid. Scheduled appt with primary care physician  who could not confirm cause of rash, even when I asked if related to vaccine, and prescribed me prednisone steroid to treat sores.
7:00 am patient received flu nasal vaccine. 1 hour later patient complained of headache. Mom took temp 102 degrees, gave TYLENOL patient slept 1 hour, then woke crying complaining of headache. Mom gave another TYLENOL dose. Temp now 98.2 she called Dr office, Dr called her back 2 hrs later and patient was having leg aches. Dr instructed mom to give MOTRIN 4- 6 hours and TYLENOL x 24 hours. Patient felt better the next day, no more fever but did have emesis that night before. No more problems.
Fever; Nausea; Soreness of Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness of Arm), PYREXIA (Fever) and NAUSEA (Nausea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included LISINOPRIL and VITAMINS NOS for an unknown indication.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced PAIN IN EXTREMITY (Soreness of Arm). On 11-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Soreness of Arm), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, Body temperature: 101 degree fahrenheit (High) 101 Degree Fahrenheit.         Action taken with mRNA-1273 in response to the event was not applicable.  No treatment medication were reported.
Seen back on 5/2/02. Mother came with the infant which had swelling and redness at the site of DTAP and Comvax. There was an indurated area about 1.5cm mainly on the upper leg than lower thigh. Lump was noted. Will be followed.
her face hurts when she chews; barely move her body; fever of 102.3F/went up to103.2F/now down to 102.0F/radiating a high fever; feels nauseous; has a terrible headache; feet are cold because of the chills; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (her face hurts when she chews), HYPOKINESIA (barely move her body), PYREXIA (fever of 102.3F/went up to103.2F/now down to 102.0F/radiating a high fever), NAUSEA (feels nauseous) and HEADACHE (has a terrible headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced FACIAL PAIN (her face hurts when she chews), HYPOKINESIA (barely move her body), PYREXIA (fever of 102.3F/went up to103.2F/now down to 102.0F/radiating a high fever), NAUSEA (feels nauseous), HEADACHE (has a terrible headache) and CHILLS (feet are cold because of the chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 UNK. At the time of the report, FACIAL PAIN (her face hurts when she chews), HYPOKINESIA (barely move her body), PYREXIA (fever of 102.3F/went up to103.2F/now down to 102.0F/radiating a high fever), NAUSEA (feels nauseous), HEADACHE (has a terrible headache) and CHILLS (feet are cold because of the chills) outcome was unknown.            No concomitant medication was given. Patient took two extra strength Tylenol and try to eat ice chips.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and unknown gender. Patient's concurrent conditions and medical history were not reported. On 02-APR-2015 the patient was vaccinated with an expired dose of PNEUMOVAX 23, lot # J005067, expiration date: 17-JAN-2015 (expiration date also reported as 07-JAN-2015); 0.5 ml, route of administration unknown. There was no concomitant medication reported. No adverse event was reported. Additional information has been requested.
After my Moderna booster my feet and hand became slightly swollen and very painful. Along with the typical side effects, this became unbearable. My hands recovered in less than a week except for one tender finger. However, my feet grew worse over the course of several weeks. Pain unbearable at night. No previous foot problems. Walked three times a week before this. Finally saw my health care provider. He is concerned booster caused this strange flare up. My Achilles and entire foot. Sent me to a foot doctor. Xrays good. Diagnosed me with Achilles tendonitis and plantar fasciitis. I do not want to believe the vaccine did this to me. But it did. Neither doctor ruled out vaccine as cause. One day I am perfectly fine. Day after booster my foot pain...both feet...became unbearable. I am on steroids. I am healthy. Exercise. Eat organic. No meds. Please please please look into this. I do not regret getting booster but will not get another until I feel it is safer. Thank you.
No other AE; Caller is a medical assistant who reports six expired doses of VAQTA were administered;; This spontaneous report was received from a medical assistant and referring to a patient of an unknown age and gender.  The patient's medical history concurrent conditions drugs reactions or allergies and concomitant medication was not provided.  On 17-JUN-2022, the patient was vaccinated with an expired dose of  hepatitis a vaccine, inactivated (VAQTA), intramuscular injection, at a dose of 0.5 milliliter once, lot number T031201, expiration date: 14-JUN-2022, as prophylaxis (strength, vaccination scheme, anatomical location of administration and route of administration were not provided) for prophylaxis (expired product administered).  It was stated that the patient had no adverse effects or symptoms from this dose. It was also mentioned that there was no previous temperature excursion.  This is one 5 reports received from the same reporter. ; Sender's Comments:  US-009507513-2206USA007065: US-009507513-2206USA007033: US-009507513-2206USA006900: US-009507513-2206USA006955: US-009507513-2206USA006951:
No adverse reactions reported to us. Patient expired 30 days after vaccinations given. Death Certificate received on 12/01/2004 states pt expereinced asphyxiation and aspiration. Autopsy Report received on 2/16/2005 states asphyxia.
Patient received vaccines on 06-06-11. The next day pt presented with a swollen, tender (L) arm (at the site where the varicella vaccine was given). 5 x 5cm area mild erythema. Apply cool compress, TYLENOL PRN - call with changes, fever or increased swelling.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. It was reported that patient received treatment of Paxlovid for COVID-19 from 17Jul2022 to 21Jul2022.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient received doses of ProQuad and Varivax on the same day; both vaccines administered "intramuscular"; This spontaneous report was received from a registered nurse referring to a 12 month old male patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.     On 23-MAY-2019, around 11:45, the patient received 0.5 ml doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S000620, expiry date on 06-JUL-2020, therapy type rHA and varicella virus vaccine live (oka/merck) (VARIVAX) lot #R010469, expiry date on 10-APR-2020; both by intramuscular route, for prophylaxis and reconstituted with sterile diluent (STERILE DILUENT).   The nurse realize that both vaccines were administered on the same day until the end of the day, they had not reached out to the mother and the mother had not called to report any adverse event.  As of reporting date, it was unknown if the patient was experiencing any adverse event from receiving measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and varicella virus vaccine live (oka/merck) (VARIVAX) at 12 months old.
Painful injection with burning sensation. Swelling and red at injection site. Itching at injection site. Site still swollen, itching and area of arm hurts.
Itchy arm, redness, tender, warm at injection site, 3 days after shot
Temp 101.6, bump on arm x 1day right arm measures 12cmx13cm. F/u in 1 day, small trace Erythema on 9/10/04.
As of Jan. 7, 2022 the Follicular Lymphomas had been spreading and growing since being detected in Dec. 2020 and diagnosed via biopsy in Feb. 2021. However, as of Jan. 26, 2022 there was noticeable shrinkage in the size of the ones at the 4 major sites detected externally. At visit with Dr. on Feb. 22, 2022 he agreed that they were significantly smaller than they were at the previous exam on Nov. 8, 2021. My primary care doc has speculated that the shrinkage may be due to the booster shot in Oct. 2021. She has observed shrinkage to the  point of not being detectable by manual exam in a long-standing cyst in a breast of a patient following a booster shot.
Was doing some preop for a surgery. Platelets were at 40 so they refused to do the surgery at that time. Went to primary doctor and count was up to 44.
Administered 9/10 on 9/13 patient returned to pharmacy. Red circle at injection site, hardened skin, severe itching, diffuse pink circle four inches in diameter around 1 inch red circle.
Diarrhea for two weeks; This case was reported by a pharmacist via call center representative and described the occurrence of diarrhea in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 3 days after receiving Shingrix, the patient experienced diarrhea. On an unknown date, the outcome of the diarrhea was recovered/resolved.   It was unknown if the reporter considered the diarrhea to be related to Shingrix.   Additional Information: GSK Receipt Date: 28-SEP-2022 Reporter's Comment: The reporter reported via chat that a patient received Shingrix vaccine and three days later got diarrhea, which had continued for two weeks.  The reporter did not provide any additional information before leaving chat.  The reporter was asked for permission to follow-up but did not respond.
Persistent numbness and pain in right foot and leg.  Numbness predominantly in foot, but would progress up to knee or mid thigh when lying down or sitting.. Pain more of a pressure/ache that moves around from bottom of foot, calf, around knee, and thigh. At night veins in bottom of foot, top of foot, and behind knee would twitch or pulse. Symptoms began around 3/29 and have continued through today (4/13). Was seen at urgent care clinic on 4/5 and doctor's office on 4/6. Began to see improvement on 4/11. Started taking Vitamin D and B12 supplements on 4/9 after results of bloodwork from 4/6 appointment. Unknown if symptoms are directly related to COVID vaccine or not, but thought it was worth sharing since my doctor mentioned seeing patients with similar symptoms after the vaccine.
Lack of effect; tested positive for COVID-19; Lack of effect; tested positive for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Mar2021 (Lot number: EL3247) at the age of 51 years as dose 2, single and administered in arm right, administration date 08Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 13Dec2021, outcome "recovering" and all described as "Lack of effect; tested positive for COVID-19". The event "lack of effect; tested positive for covid-19" and "lack of effect; tested positive for covid-19" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (12Dec2021) positive. No other vaccine was administered in four weeks. The patient was not diagnosed with COVID-19 prior vaccination.  Follow-up (16Dec2021): Follow-up attempts are completed. No further information is expected.
Initial fatigue, muscle soreness starting at ~3pm. Slept until 9/10 am following day. Following day continued to be exhausted, low energy, unable to perform regular tasks. on Monday, 5/17 developed sudden face rash, concentrated largely on one side, spread over the nose, and a little bit on the other cheek as well. Rash was raised symmetrical bumps, smaller than a quarter centimeter with pussy-filled whiteheads, and swelling particularly concentrated around the nose. Rash was itchy and hot. Eyes were dry and itchy. Rash persisted through the evening/night, and the swelling went down (still visible) for the following morning.
Information has been received from a physician assistant concerning an approximately 20 year old female who was vaccinated the second dose of GARADSIL. A few days post the second dose the patient broke out in a rash all over her body. The patient sought medical attention. Treatment was BENADRYL, the patient recovered. The physician assistant indicated the patient would not be completing the vaccine series. This is one of several reports from the same source. Additional information has been requested.
Had the following symptoms after being vaccinated: -chills -body aches/generalized -joint pain/generalized -fever -headache -fatigue -swelling/pain at site of vaccination/photos available
Stomach ache, headache, joint and muscle soreness, fatigue,  extreme soreness and pain at injection site, and malaise.
This spontaneous prospective pregnancy report was received form a 26 year old female consumer (reporting on herself). The patient's current condition included Hashimoto's and drug reaction allergy to penicillin. On 18-APR-2013 the patient was vaccinated with GARDASIL (lot number and expiration date not reported) (dose and route not reported, in the right hip). Concomitant therapies included SYNTHROID (dose and manufacturer unspecified). The patient reported that was 28 weeks pregnant (last menstrual period on 05-OCT-2012) and the physician contacted her on 19-APR-2013 to inform that she received the GARDASIL vaccine instead of the Rhogam Shot. The patient stated she nearly passed out after receiving the vaccine, and today (19-APR-2013) she was experiencing headache, nausea and vomiting. The patient did not sought medical attention and no treatment was provided for the adverse events. The patient was in the third trimester when the exposure to the GARDASIL occurred, the pregnancy outcome was pending and the fetal outcome was unknown. It was reported that a Blood work/Glucose testing was made with no results reported. At the time of the report the patient's outcome was unknown. Additional information is not expected.
I experienced the feeling of gasping for air and no medications were working for me. I went to the ER where I was diagnosed with parainfluenza COPD. The symptoms have remained, I am unable to vacuum my house without becoming out of breath and taking breaks, and I am experiencing shortness of breathe with fatigue daily which has hindered my daily activities. I had a lung scope done late 11/2021 they found that I had Aspergillosis, and cleaned out what was possible. I have been referred to get thermoplastisis on my at a later date.
EVENT: PT had her 2nd Covid vaccination on 06/08/21 and then 3 days later has a heart attack and was hospitalized for 9 days. PT says she still doesn&apos;t feel 100% percent all these months later.
Severe headache with photosentitivity, phonophobia, fever 104, deteriorated rapidly in clinic with + Kernigs sign and nystagmus, sluggish pupils
11/27/2021 - Arrived in ED with respiratory distress. O2 sat in 50s. Placed on CPAP by EMS with attenuation in 90s. Saturating 68% on CPAP in ED. HR 122, RR 20. S/P 1 day right AKA revision. Patient intubated/sedated and placed on vent. ABG 7.31/48/223/24. Covid positive on admit. Covid negative 11/23. CTA shows emphysema and b/l lower lobe small lung infiltrates. No PE. Admit covid pneum/sepsis. Vanco/Cefepime/Doxy started - Solumedrol/pulmicort/performist/duoneb. Already on Rivaroxaban. Baricitinib ordered.  11/28 - On PSV then extubated - tolerating well on 4LNC. Continuing with Doxy/Cefepime/Vanco/Solumedrol. Change nebs to inhalers. C/W baricitinib and remdisivir.   Receiving 2 PRBC for acute anemia - Hem 6.6 - 10.8 post infusion.  11/30 - MRSA negative - Vanco d/c - started on Levofloxacin. Transferred from ICU to inpatient floor. Titrated off O2.  12/1 - Acute hypoxemia/respiratory failure now improved. Current regimen continued.  12/2 - Patient improved. Discharged to home with Covid at Home.
Subsequent to dose 1 of Engerix B the pt experienced shortness of breath. Outcome unknown. Subsequent to dose 2 of Engerix B the pt again experienced shortness of breath and was seen in the ER. The most recent information received reports the outcome of the event as unknown.
Patient c/o feeling dizzy and passed out after receiving vaccines. Was unresponsive with eyes rolled back in head, pallor, dilated pupils and short period of apnea.  It almost appeared that he had a seizure.  Became responsive after about 10-15 seconds.  Vitals were stable with color returning after about 10 minutes.  Pt. no longer felt dizzy before leaving area.  Was coherent and responding appropriately to questions.  States that he had never had this type of response to vaccines prior to this.
2 weeks after first covid vaccine, chest pain occured in left upper chest of vaccinated patient. Sharp pain randomly. Difficult to breathe full lung of air and difficult to release full lung of air.
The nurse vaccintor brought patient to the EMS room after the vaccine was administered. Patient says she felt light headed or nauseated. In EMS room at 1403, patient denies lightheadedness or nausea. Patient states she has a history of feeling faint with vaccines, and she does not have any symptoms now.
pain and soreness on the right side of his body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain and soreness on the right side of his body) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced PAIN (pain and soreness on the right side of his body). In February 2021, PAIN (pain and soreness on the right side of his body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.    This case was linked to MOD-2021-033433 (Patient Link).
Information has been received from a physician, concerning a 25 year old female patient, with no history of a reaction when vaccinated with the first dose of Gardasil, who on 07-AUG-2007 was vaccinated IM in the right arm, with the second dose, 0.5ml, of Gardasil (Lot #658219/0680U).  There was no concomitant medication.  On 08-AUG-2007, the patient reported she had been experiencing nausea.  At the time of this report, the patient had not recovered from the event.  The patient sought unspecified medical attention.  Additional information has been requested.
Nurse reported PROQUAD was given to a 50 year old patient/ pediatric dose administered to adult patient; No adverse event; This spontaneous report has been received from a registered nurse concerning a 50 year-old-patient of unknown gender. The patient's concurrent conditions, known allergies/reactions, medical history and concomitant medications were not reported.   The reporter stated that a pediatric dose was administered to an adult patient, as on an unspecified date, a dose of measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was given to the 50-year-old patient (batch/lot No, expiration date; dose and route of administration were not reported) (product administered to patient of inappropriate age) for prophylaxis. No additional adverse event was reported.